Cellular response to β‐amyloid neurotoxicity in Alzheimer's disease and implications in new therapeutics
Abstract β‐Amyloid (Aβ) is a specific pathological hallmark of Alzheimer's disease (AD). Because of its neurotoxicity, AD patients exhibit multiple brain dysfunctions. Disease‐modifying therapy (DMT) is the central concept in the development of AD therapeutics today, and most DMT drugs that are...
Main Authors: | Haolin Zhang, Xianghua Li, Xiaoli Wang, Jiayu Xu, Felice Elefant, Juan Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-02-01
|
Series: | Animal Models and Experimental Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ame2.12313 |
Similar Items
-
Recent Advances in the Molecular and Cellular Mechanisms of gp120-Mediated Neurotoxicity
by: Valeria Avdoshina, et al.
Published: (2022-05-01) -
Neurotrophins as Key Regulators of Cell Metabolism: Implications for Cholesterol Homeostasis
by: Mayra Colardo, et al.
Published: (2021-05-01) -
The p75 neurotrophin receptor in AgRP neurons is necessary for homeostatic feeding and food anticipation
by: Brandon Podyma, et al.
Published: (2020-01-01) -
Evidence of p75 Neurotrophin Receptor Involvement in the Central Nervous System Pathogenesis of Classical Scrapie in Sheep and a Transgenic Mouse Model
by: Tomás Barrio, et al.
Published: (2021-03-01) -
Overexpression of p75<sup>NTR</sup> in Human Seminoma: A New Biomarker?
by: Anna Perri, et al.
Published: (2021-06-01)